Kentucky 2025 2025 Regular Session

Kentucky House Bill HB710 Engrossed / Bill

                    UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 1 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
AN ACT relating to licensees authorized to prescribe or dispense controlled 1 
substances. 2 
Be it enacted by the General Assembly of the Commonwealth of Kentucky: 3 
Section 1.   KRS 218A.205 is amended to read as follows: 4 
(1) As used in this section: 5 
(a) "Reporting agency" includes: 6 
1. The Department of Kentucky State Police; 7 
2. The Office of the Attorney General; 8 
3. The Cabinet for Health and Family Services; and 9 
4. The applicable state licensing board; and 10 
(b) "State licensing board" means: 11 
1. The Kentucky Board of Medical Licensure; 12 
2. The Kentucky Board of Nursing; 13 
3. The Kentucky Board of Dentistry; 14 
4. The Kentucky Board of Optometric Examiners; 15 
5. The State Board of Podiatry; and 16 
6. Any other board that licenses or regulates a person who is entitled to 17 
prescribe or dispense controlled substances to humans. 18 
(2) (a) When a reporting agency or a law enforcement agency receives a report of 19 
improper, inappropriate, or illegal prescribing or dispensing of a controlled 20 
substance it may, to the extent otherwise allowed by law, send a copy of the 21 
report within three (3) business days to every other reporting agency. 22 
(b) A county attorney or Commonwealth's attorney shall notify the Office of the 23 
Attorney General and the appropriate state licensing board within three (3) 24 
business days of an indictment or a waiver of indictment becoming public in 25 
his or her jurisdiction charging a licensed person with a felony offense 26 
relating to the manufacture of, trafficking in, prescribing, dispensing, or 27  UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 2 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
possession of a controlled substance. 1 
(3) Each state licensing board shall, in consultation with the Kentucky Office of Drug 2 
Control Policy, establish the following by administrative regulation promulgated in 3 
accordance with KRS Chapter 13A for those licensees authorized to prescribe or 4 
dispense controlled substances: 5 
(a) Mandatory prescribing and dispensing standards related to controlled 6 
substances, the requirements of which shall include the diagnostic, treatment, 7 
review, and other protocols and standards established for Schedule II 8 
controlled substances and Schedule III controlled substances containing 9 
hydrocodone under KRS 218A.172 and which may include the exemptions 10 
authorized by KRS 218A.172(4); 11 
(b) In accordance[accord] with the CDC Guideline for Prescribing Opioids for 12 
Chronic Pain published in 2016, a prohibition on a practitioner issuing a 13 
prescription for a Schedule II controlled substance for more than a three (3) 14 
day supply of a Schedule II controlled substance if the prescription is intended 15 
to treat pain as an acute medical condition, with the following exceptions: 16 
1. The practitioner, in his or her professional judgment, believes that more 17 
than a three (3) day supply of a Schedule II controlled substance is 18 
medically necessary to treat the patient's pain as an acute medical 19 
condition and the practitioner adequately documents the acute medical 20 
condition and lack of alternative treatment options which justifies 21 
deviation from the three (3) day supply limit established in this 22 
subsection in the patient's medical records; 23 
2. The prescription for a Schedule II controlled substance is prescribed to 24 
treat chronic pain; 25 
3. The prescription for a Schedule II controlled substance is prescribed to 26 
treat pain associated with a valid cancer diagnosis; 27  UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 3 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
4. The prescription for a Schedule II controlled substance is prescribed to 1 
treat pain while the patient is receiving hospice or end-of-life treatment 2 
or is receiving care from a certified community based palliative care 3 
program; 4 
5. The prescription for a Schedule II controlled substance is prescribed as 5 
part of a narcotic treatment program licensed by the Cabinet for Health 6 
and Family Services; 7 
6. The prescription for a Schedule II controlled substance is prescribed to 8 
treat pain following a major surgery or the treatment of significant 9 
trauma, as defined by the state licensing board in consultation with the 10 
Kentucky Office of Drug Control Policy; 11 
7. The Schedule II controlled substance is dispensed or administered 12 
directly to an ultimate user in an inpatient setting; or 13 
8. Any additional treatment scenario deemed medically necessary by the 14 
state licensing board in consultation with the Kentucky Office of Drug 15 
Control Policy. 16 
 Nothing in this paragraph shall authorize a state licensing board to promulgate 17 
regulations which expand any practitioner's prescriptive authority beyond that 18 
which existed prior to June 29, 2017; 19 
(c) A prohibition on a practitioner dispensing greater than a forty-eight (48) hour 20 
supply of any Schedule II controlled substance or a Schedule III controlled 21 
substance containing hydrocodone unless the dispensing is done as part of a 22 
narcotic treatment program licensed by the Cabinet for Health and Family 23 
Services; 24 
(d) A procedure for temporarily suspending, limiting, or restricting a license held 25 
by a named licensee where a substantial likelihood exists to believe that the 26 
continued unrestricted practice by the named licensee would constitute a 27  UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 4 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
danger to the health, welfare, or safety of the licensee's patients or of the 1 
general public; 2 
(e) A procedure for the expedited review of complaints filed against their 3 
licensees pertaining to the improper, inappropriate, or illegal prescribing or 4 
dispensing of controlled substances that is designed to commence an 5 
investigation within seven (7) days of a complaint being filed and produce a 6 
charging decision by the board on the complaint within one hundred twenty 7 
(120) days of the receipt of the complaint, unless an extension for a definite 8 
period of time is requested by a law enforcement agency due to an ongoing 9 
criminal investigation; 10 
(f) The establishment and enforcement of licensure standards that conform to the 11 
following: 12 
1. Restrictions that may include a[ permanent] ban on licensees and 13 
applicants convicted[ after July 20, 2012,] in this state or any other state 14 
of any felony offense relating to[ controlled substances from] 15 
prescribing or dispensing a controlled substance; 16 
2. Restrictions that may include[short of] a[ permanent] ban on licensees 17 
and applicants convicted in this state or any other state of any 18 
misdemeanor offense relating to prescribing or dispensing a controlled 19 
substance; 20 
3. Restrictions mirroring in time and scope any disciplinary limitation 21 
placed on a licensee or applicant by a licensing board of another state if 22 
the disciplinary action results from improper, inappropriate, or illegal 23 
prescribing or dispensing of controlled substances; and 24 
4. A requirement that licensees and applicants report to the board any 25 
conviction or disciplinary action covered by this subsection with 26 
appropriate sanctions for any failure to make this required report; 27  UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 5 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
(g) A procedure for the continuous submission of all disciplinary and other 1 
reportable information to the National Practitioner Data Bank of the United 2 
States Department of Health and Human Services; 3 
(h) If not otherwise required by other law, a process for submitting a query on 4 
each applicant for licensure to the National Practitioner Data Bank of the 5 
United States Department of Health and Human Services to retrieve any 6 
relevant data on the applicant; and 7 
(i) Continuing education requirements beginning with the first full educational 8 
year occurring after July 1, 2012, that specify that at least seven and one-half 9 
percent (7.5%) of the continuing education required of the licensed 10 
practitioner relate to the use of the electronic monitoring system established in 11 
KRS 218A.202, pain management, or addiction disorders. 12 
(4) For the purposes of pharmacy dispensing, the medical necessity for a Schedule II 13 
controlled substance as documented by the practitioner in the patient's medical 14 
record and the prescription for more than a three (3) day supply of that controlled 15 
substance are presumed to be valid. 16 
(5) A state licensing board shall employ or obtain the services of a specialist in the 17 
treatment of pain and a specialist in drug addiction to evaluate information received 18 
regarding a licensee's prescribing or dispensing practices related to controlled 19 
substances if the board or its staff does not possess such expertise, to ascertain if the 20 
licensee under investigation is engaging in improper, inappropriate, or illegal 21 
practices. 22 
(6) Any statute to the contrary notwithstanding, no state licensing board shall require 23 
that a grievance or complaint against a licensee relating to controlled substances be 24 
sworn to or notarized, but the grievance or complaint shall identify the name and 25 
address of the grievant or complainant, unless the board by administrative 26 
regulation authorizes the filing of anonymous complaints. Any such authorizing 27  UNOFFICIAL COPY  	25 RS HB 710/GA 
Page 6 of 6 
HB071010.100 - 1961 - XXXX   3/6/2025 2:26 PM  	GA 
administrative regulation shall require that an anonymous complaint or grievance be 1 
accompanied by sufficient corroborating evidence as would allow the board to 2 
believe, based upon a totality of the circumstances, that a reasonable probability 3 
exists that the complaint or grievance is meritorious. 4 
(7) Every state licensing board shall cooperate to the maximum extent permitted by law 5 
with all state, local, and federal law enforcement agencies, and all professional 6 
licensing boards and agencies, state and federal, in the United States or its 7 
territories in the coordination of actions to deter the improper, inappropriate, or 8 
illegal prescribing or dispensing of a controlled substance. 9 
(8) Each state licensing board shall require a fingerprint-supported criminal record 10 
check by the Department of Kentucky State Police and the Federal Bureau of 11 
Investigation of any applicant for initial licensure to practice any profession 12 
authorized to prescribe or dispense controlled substances. 13